Price movement over the last 24 hours
ARK Genomic Revolution ETF vs ON Holding AG — how do they compare? ARK Genomic Revolution ETF trades at $40.83, while ON Holding AG trades at $38.3 (market cap $12.85B). The key difference: ARK Genomic Revolution ETF is trading nearer its 52-week high, ON Holding AG nearer its low. Which is the better fit depends on your goals.
| ARKG | ONON | |
|---|---|---|
Sector | Sector/Thematic | Technology |
52-Week High | $43.57 | $54.24 |
52-Week Low | $23.09 | $31.88 |
Market Cap | — | $12.85B |
Enterprise Value | — | $12.17B |
Signals from Pluang's Aura AI — not financial advice
ARKG trades at $41.32, down 3.91% today, with a bullish technical signal driven by moving averages. Recent news highlights biotech ETF strength in June 2026, fueled by strong earnings, M&A activity, and AI-driven drug discovery optimism. Key support lies at $40, with resistance at $44.
The outlook remains positive given sector tailwinds, but risks include regulatory hurdles and market volatility. Investor sentiment is buoyed by industry growth catalysts, though selective investment approaches are noted by analysts.
ONON trades at $38.54, up 4.81% today, with strong earnings beats in recent quarters. The stock shows bearish technical signals but benefits from robust fundamentals including 63.88% gross margins and 15.5% ROE. Analyst sentiment is overwhelmingly positive with a $47.33 consensus target, though technical indicators suggest near-term resistance at $39.
Outlook remains favorable given consistent earnings outperformance and margin expansion, but elevated valuation multiples and bearish technical trends present near-term risks. The primary opportunity lies in continued execution against growth targets, while risks include market volatility and competitive pressures in the athletic apparel sector.
Trailing returns across standard periods
ARKG is an actively managed ETF that invests in the genomic revolution. It focuses on companies leading in gene editing, CRISPR technology, therapeutics, and molecular diagnostics, including firms like CRISPR Therapeutics and Tempus AI.
Read more on ARKG →ON Holding AG is a Swiss sports company primarily known for its high-performance running shoes, apparel, and accessories under the 'On' brand. The company emphasizes a blend of high-end design, proprietary cloud technology (like CloudTec cushioning), and sustainability in its products. On has rapidly gained market share globally, appealing to both competitive athletes and general consumers in the performance and lifestyle footwear segments.
Read more on ONON →